Search - tctmd.com

Displaying 21 - 40 of 381

Sort: Relevancy | Date

News Conference News SCCT 2024

AI Assessment of Plaque, Hemodynamics May ID Lesion-Specific ACS Risk

Todd Neale

July 25, 2024

News Features

Let’s Talk About Sex: How Best to Broach Post-MI Conversations

Caitlin E. Cox

June 14, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

Presentation EuroPCR 2024

QFR for the revascularization of non-culprit lesions of older patients with myocardial infarction

Presenter: Andrea Erriquez

May 14, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Conference News ACC 2024

Telemedicine Strategy After MI Scores a Win in TELE-ACS

Caitlin E. Cox

April 12, 2024

News Conference News ACC 2024

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Michael O'Riordan

April 07, 2024

News Conference News

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

L.A. McKeown

February 02, 2024

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Conference News AHA 2023

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

L.A. McKeown

November 11, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

Presentation ESC 2023

Functional versus Culprit only Revascularization in Elderly Patients with Myocardial Infarction and Multivessel Disease

Presenter: Simone Biscaglia

August 28, 2023

News Conference News ESC 2023

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

Caitlin E. Cox

August 26, 2023

News Conference News ESC 2023

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

Michael O'Riordan

August 26, 2023

News Daily News

High-Sensitivity Troponin Assays May Stratify Risk in Chronic CAD

Todd Neale

August 01, 2023

News Conference News EuroPCR 2023

QFR More Consistent Than FFR in Nonculprit Lesions After STEMI

Caitlin E. Cox

May 24, 2023

News Daily News

To Boost Access and Outcomes With New PCI Centers, Location Matters

L.A. McKeown

May 08, 2023

News Daily News

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

Todd Neale

May 05, 2023

News Conference News ACC 2023

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Michael O'Riordan

March 13, 2023

Advertisement

AI Assessment of Plaque, Hemodynamics May ID Lesion-Specific ACS Risk

Let’s Talk About Sex: How Best to Broach Post-MI Conversations

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

QFR for the revascularization of non-culprit lesions of older patients with myocardial infarction

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Telemedicine Strategy After MI Scores a Win in TELE-ACS

Another Beta-blocker Blow: REDUCE-AMI Confirms No Benefit After Acute MI

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

Top Coronary Artery Disease News of 2023

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

October 2023 News Roundup

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Functional versus Culprit only Revascularization in Elderly Patients with Myocardial Infarction and Multivessel Disease

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

High-Sensitivity Troponin Assays May Stratify Risk in Chronic CAD

QFR More Consistent Than FFR in Nonculprit Lesions After STEMI

To Boost Access and Outcomes With New PCI Centers, Location Matters

Swedish Study Adds to Evidence That Beta-blockers May Not Be Needed Long After MI

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content